Clinical overview
Quick answer
Opioid tolerance can fall quickly during detoxification, hospitalisation, incarceration, residential treatment, or a period of non-use. Returning to a previously tolerated amount can cause fatal overdose.
What this means
Reduced tolerance is predictable but the exact degree is not. Fentanyl contamination and depressant combinations add further uncertainty.
Key distinctions
- Provide naloxone, medication treatment, and a concrete safety plan
- never frame completion of detox as immunity from overdose.
Signs and patterns clinicians assess
A clinician looks at the pattern over time, its severity, the person’s baseline, and the consequences—not at one isolated behaviour. Relevant features can include:
- craving, loss of control, or use outside the prescribed plan
- sedation, pinpoint pupils, slowed breathing, constipation, or repeated intoxication
- continued use despite overdose, health, relationship, financial, or legal harms
- withdrawal symptoms such as aches, sweating, diarrhoea, nausea, anxiety, and insomnia
- return to use after detox or abstinence, when reduced tolerance can sharply increase overdose risk
These signs are not a self-diagnosis. Intoxication, withdrawal, prescribed use, pain, sleep disorders, and mental-health conditions can overlap, so assessment should establish what is happening and what is immediately unsafe.
Health and safety risks
Risk depends on the substance or medicine, route, dose, frequency, combinations, physical health, mental health, and environment. Important concerns include:
- fatal respiratory depression and overdose
- unpredictable potency, especially with illicit fentanyl and mixed drug supplies
- infection and vascular injury when drugs are injected
- dangerous sedation when combined with alcohol, benzodiazepines, gabapentinoids, or other depressants
- loss of tolerance after detoxification, incarceration, hospitalisation, or residential treatment
Assessment and treatment
Good care starts with consent, dignity, and a clear assessment of immediate risk. Treatment intensity should be matched to clinical need rather than to marketing labels or a fixed programme length.
- rapid access to an opioid-use assessment and overdose-prevention plan
- naloxone access and training for the person and people around them
- evidence-based medication such as buprenorphine or methadone where available and appropriate
- management of pain, mental health, infection risk, housing, and social needs
- continuing care rather than detoxification as a stand-alone intervention
Recovery plans should state who is responsible for medication, crisis support, physical-health follow-up, family communication, and continuing care. A lapse should trigger prompt reassessment and additional support—not abandonment or shame.
When to seek urgent help
Suspect opioid overdose when a person is unresponsive, breathing slowly or not at all, making choking or gurgling sounds, or has blue/grey lips or fingertips. Call emergency services, give naloxone if available, provide rescue breathing or CPR as trained, and stay until help arrives.
Questions to ask a treatment provider
- Who performs the medical and psychiatric assessment, and what are their current qualifications and registrations?
- How is withdrawal, overdose, suicide risk, medication, and physical illness managed?
- Which treatments are offered for this specific condition, and what evidence supports them?
- What happens if symptoms worsen or hospital care is required?
- How are outcomes, complaints, safeguarding, discharge, and continuing care handled?
Frequently asked questions
Can this condition be treated?
Yes. Treatment should be matched to the substance or behaviour, severity, withdrawal and overdose risk, physical and mental health, previous response, goals, and available support. More than one episode of care may be needed.
Does withdrawal mean someone has an addiction?
Not necessarily. Withdrawal can indicate physical dependence, including during appropriate prescribed treatment. Addiction additionally involves impaired control, prioritisation, and continued use despite harm. A clinician can distinguish these patterns.
What is the safest first step?
Arrange a confidential assessment with a qualified addiction or medical service. Use emergency services immediately for overdose, seizure, breathing difficulty, severe confusion, dangerous psychosis, or immediate suicide risk.
Sources and clinical guidance
Sources are selected for clinical authority and public accessibility. Publication does not imply endorsement of any treatment provider.